WATMIND USA, INC

WATMIND USA, INC specializes in the manufacturing of in-vitro diagnostic substances, with a demonstrated focus on multi-antigen test systems designed for rapid deployment during public health emergencies. The company’s technical expertise lies in the development and production of molecular and immunoassay-based diagnostic reagents capable of simultaneously detecting multiple pathogens, including SARS-CoV-2 and Influenza A/B. Their capability centers on scalable, GMP-aligned manufacturing processes that ensure batch consistency, regulatory compliance, and rapid turnaround under surge conditions. Key differentiators include precision formulation of antigen panels, optimized assay sensitivity and specificity, and supply chain readiness for high-volume diagnostic production in response to evolving infectious disease threats. The contractor has delivered critical diagnostic manufacturing services to the Department of Health and Human Services, aligning with its mission to strengthen national preparedness for respiratory pathogen surges. This engagement reflects a targeted relationship focused on biodefense and public health infrastructure resilience, where WATMIND USA, INC provides essential laboratory reagents that support federal diagnostic testing networks during emergency response scenarios. The firm’s primary industry focus is on NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—placing it squarely within the clinical diagnostics and public health biomanufacturing sector. The company operates at the intersection of infectious disease surveillance and diagnostic supply chain security, specializing in high-complexity reagent production for government-funded surveillance and outbreak response programs. WATMIND USA, INC is structured as a small business (2L entity) headquartered in Jackson, Mississippi. While no formal government certifications are currently listed, its operational model supports federal procurement requirements for medical countermeasure production, positioning it as a niche supplier within the federal diagnostic supply ecosystem. The company’s geographic presence supports regional manufacturing resilience and federal logistics networks in the southeastern United States.